Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

(NQ: )

N/A UNCHANGED
Last Price Updated: Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about

< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Lexicon Announces Selection Of Manuscript To Be Presented At The American Diabetes Association Diabetes Care Symposium
Results from Clinical Study of Sotagliflozin in Type 1 Diabetes Patients 
From PR Newswire
Lexicon to Present at the Bank of America Merrill Lynch 2015 Health Care Conference
From PR Newswire
Lexicon Announces One For Seven Reverse Stock Split Effective May 20, 2015
Stockholders Overwhelmingly Approved Authorization for Reverse Stock Split 
From PR Newswire
Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2015 First Quarter Financial Results
Conference Call and Webcast at 5:00 p.m. Eastern Time 
From PR Newswire
Lexicon To Report First Quarter 2015 Financial Results On April 29, 2015
Conference Call and Webcast to Follow 
From PR Newswire
Market Updates on Biotech Stocks -- Lexicon Pharma, Idera Pharma, Synta Pharma, Spectrum Pharma, and Medivation
From PR Newswire
Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research
In the search for neuroscience drug discovery treatments, Alzheimer's disease and specifically autism drug candidates, a few viable ... 
Tags ARNA NTRP CYTR
From Benzinga
Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research
From PR Newswire
Lexicon Pharmaceuticals and Bristol-Myers Squibb Select Development Candidate for Neuropathic Pain in Neuroscience Drug Discovery and Development Alliance
From PR Newswire
Jefferies: 10 Buyout Targets To Own During The M&A Boom
In a new report, analysts at Jefferies discussed the current merger and acquisition environment. The report included a breakdown of ... 
Tags BIOS NUVA Jefferies
From Benzinga
Lexicon To Present At Needham & Company's 14th Annual Healthcare Conference
From PR Newswire
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) to Ring The Nasdaq Stock Market Closing Bell
From GlobeNewswire News Releases
Lexicon Pharmaceuticals Announces First Patient Screened In Pivotal Phase 3 Clinical Trial Of Sotagliflozin
From PR Newswire
Technical Pulse on Biotech Stocks -- Geron, Lexicon Pharma, XOMA Corp., Spectrum Pharma, and BioLine RX
From PR Newswire
Lexicon and Ipsen Expand Their Licensing and Commercialization Agreement for Telotristat Etiprate to Include Canada
From PR Newswire
Advances in Biotech Expanded Studies Lead to Cutting-Edge Therapeutic Treatments - Company Announces Positive Final Results in Treatment for Alzheimer's Disease
From PR Newswire
Lexicon Pharma Announces Closing of Enrollment in Pivotal Phase 3 Clinical Trial of Telotristat Etiprate
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human ... 
Tags Biotechnology FDA Press Releases
From Benzinga
Lexicon Pharmaceuticals Completes Enrollment In Pivotal Phase 3 Clinical Trial Of Telotristat Etiprate
Top-Line Results Expected in the 3rd Quarter of 2015 
From PR Newswire
Hot Stock: Lexicon Pharmaceuticals, Shares Gain 7.2% (LXRX)
From Comtex SmarTrend® News Briefs
Morning Market Gainers
Infosonics Corp. (NASDAQ: IFON) shares surged 61.82% to $2.75. Infosonics reported Q4 earnings of $0.05 per share on revenue of $17.9 ... 
Tags NVGN IFON CRMD
From Benzinga
UPDATE: Lexicon Pharmaceuticals Shares Surge On Upbeat Q4 Results
Shares of Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) jumped more than 8% in pre-market trading after the company reported ... 
Tags Earnings Benzinga LXRX
From Benzinga
Lexicon Pharmaceuticals (LXRX) Tops 4Q Forecasts
Lexicon Pharmaceuticals, Inc. (LXRX) shares are up more than 5% to $1.03 in pre-market trading Wednesday after the company reported its fourth quarter earnings results. The biopharmaceutical firm... 
Tags News Markets Latest
From Wall Street Pit
Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2014 Fourth Quarter And Full Year Financial Results
Conference Call and Webcast at 10:00 a.m. Eastern Time 
From PR Newswire
Earnings Scheduled For March 4, 2015
Abercrombie & Fitch Co. (NYSE: ANF) is expected to report its Q4 earnings at $1.15 per share on revenue of $1.17 billion. American ... 
Tags Earnings COKE CCSC
From Benzinga
Lexicon To Report Fourth Quarter And Year End 2014 Financial Results On March 4, 2015
Conference Call and Webcast to Follow 
From PR Newswire
Lexicon To Present At The Cowen 35th Annual Health Care Conference
From PR Newswire
Lexicon Announces Management Change
From PR Newswire
Expert Briefing on Biotech Stocks - Lexicon Pharma, Sunesis Pharma, Navidea Biopharma, Tekmira Pharma, and Intrexon
From PR Newswire
Lexicon To Present At The BIO CEO & Investor Conference
From PR Newswire
Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 3
The J.P. Morgan Healthcare Conference runs this week from January 12 to 15. This healthcare conference is one of the largest and most ... 
Tags SLXP NVAX AZN
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.